"Neoplasm Staging" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.
| Descriptor ID |
D009367
|
| MeSH Number(s) |
E01.789.625
|
| Concept/Terms |
Neoplasm Staging- Neoplasm Staging
- Staging, Neoplasm
- Tumor Staging
- Staging, Tumor
- Cancer Staging
- Staging, Cancer
TNM Staging- TNM Staging
- Staging, TNM
- TNM Staging System
- Staging System, TNM
- Staging Systems, TNM
- System, TNM Staging
- Systems, TNM Staging
- TNM Staging Systems
- TNM Classification
- Classification, TNM
- Classifications, TNM
- TNM Classifications
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Staging".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Staging".
This graph shows the total number of publications written about "Neoplasm Staging" by people in this website by year, and whether "Neoplasm Staging" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 11 | 11 |
| 1997 | 1 | 16 | 17 |
| 1998 | 1 | 17 | 18 |
| 1999 | 2 | 15 | 17 |
| 2000 | 0 | 31 | 31 |
| 2001 | 1 | 20 | 21 |
| 2002 | 0 | 13 | 13 |
| 2003 | 2 | 22 | 24 |
| 2004 | 2 | 17 | 19 |
| 2005 | 2 | 32 | 34 |
| 2006 | 0 | 32 | 32 |
| 2007 | 2 | 46 | 48 |
| 2008 | 2 | 56 | 58 |
| 2009 | 1 | 43 | 44 |
| 2010 | 2 | 62 | 64 |
| 2011 | 4 | 52 | 56 |
| 2012 | 2 | 57 | 59 |
| 2013 | 4 | 62 | 66 |
| 2014 | 4 | 77 | 81 |
| 2015 | 2 | 72 | 74 |
| 2016 | 11 | 58 | 69 |
| 2017 | 5 | 68 | 73 |
| 2018 | 5 | 57 | 62 |
| 2019 | 11 | 57 | 68 |
| 2020 | 2 | 47 | 49 |
| 2021 | 1 | 41 | 42 |
| 2022 | 0 | 25 | 25 |
| 2023 | 1 | 25 | 26 |
| 2024 | 16 | 34 | 50 |
| 2025 | 0 | 30 | 30 |
| 2026 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Staging" by people in Profiles.
-
Stage I Triple-Negative Breast Cancer: Moving From One-Size-Fits-All to a Personalized Approach. Am Soc Clin Oncol Educ Book. 2026 Jun; 46(3):e520666.
-
Personalizing Curative Therapy in Stage II to III Triple-Negative Breast Cancer. Am Soc Clin Oncol Educ Book. 2026 Jun; 46(3):e520834.
-
Neighborhood-Level Social Vulnerability, Race and Ethnicity, and Stage at Diagnosis: A Population-Based Study of 12,957 Patients with Oral Cavity Cancer. Cancer Epidemiol Biomarkers Prev. 2026 Mar 02; 35(3):398-405.
-
Triple negative breast cancer: what clinical progress have we seen in the last 5?years? Expert Opin Investig Drugs. 2026 Mar; 35(3):223-238.
-
Race and neighborhood disadvantage in patients with stage I-III endometrioid endometrial carcinoma treated at a tertiary referral center. Gynecol Oncol. 2025 Oct; 201:203-209.
-
Procedure Patterns and Survival in Advanced Non-Small Cell Lung Cancer With Malignant Airway Obstruction: A Surveillance, Epidemiology, and End Results Medicare Analysis. Chest. 2026 Feb; 169(2):538-549.
-
Carboplatin, gemcitabine, and mifepristone for advanced breast and recurrent/persistent epithelial ovarian cancer. Breast Cancer Res Treat. 2025 Oct; 213(3):347-354.
-
Durvalumab Plus Platinum-Etoposide in Extensive-Stage Small-Cell Lung Cancer: Outcomes in Age, Sex, and Platinum Subgroups From the Phase 3 CASPIAN Study. Clin Lung Cancer. 2025 Dec; 26(8):626-641.
-
Interobserver Reproducibility of Pelvicalyceal Invasion in Renal Cell Carcinoma Nephrectomies Among Genitourinary Pathologists. Am J Surg Pathol. 2025 Dec 01; 49(12):1307-1314.
-
Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial. Ann Surg Oncol. 2025 Oct; 32(11):8211-8219.